Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Cash & Equivalents (2020 - 2025)

908 Devices (MASS) has disclosed Cash & Equivalents for 6 consecutive years, with $70.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 60.15% to $70.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.5 million through Dec 2025, up 60.15% year-over-year, with the annual reading at $70.5 million for FY2025, 60.15% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $70.5 million at 908 Devices, up from $62.8 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $224.1 million in Q4 2021, with the low at $44.0 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $126.0 million, with a median of $127.0 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents skyrocketed 1146.7% in 2021, then plummeted 64.8% in 2024.
  • Over 5 years, Cash & Equivalents stood at $224.1 million in 2021, then decreased by 15.91% to $188.4 million in 2022, then crashed by 35.76% to $121.0 million in 2023, then plummeted by 63.62% to $44.0 million in 2024, then soared by 60.15% to $70.5 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $70.5 million, $62.8 million, and $61.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.